Clinical Trial

Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 9, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-15; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2025-06-24
Trial Details
NCT Number NCT06933381
Lead Sponsor Queen's Medical Center
Collaborators: Lakshmi Devi and Devraj Sharma Endowment
Conditions Reducing Pain With Nexplanon Implant Insertion
Enrollment 70 participants
Start Date 2025-06-16
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-09